论文信息 - The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia

The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia

Platelet transfusions are commonly used to treat critically ill patients with thrombocytopenia. Whether platelet transfusions are associated with a reduction in the risk of major bleeding is unknown.

[1] B. Rochwerg,et al. Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry. , 2016, Chest.

[2] T. van der Poll,et al. Transfusion of platelets, but not of red blood cells, is independently associated with nosocomial infections in the critically ill , 2016, Annals of Intensive Care.

[3] D. Devine,et al. 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium , 2015, Transfusion.

[4] R. Goel,et al. Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. , 2015, Blood.

[5] S. Ricci,et al. Platelet transfusion strategy for hematologic cancers , 2015, Internal and Emergency Medicine.

[6] S. Stanworth,et al. Platelet transfusions for critically ill patients with thrombocytopenia. , 2014, Blood.

[7] D. Cook,et al. Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. , 2013, Chest.

[8] D. Cook,et al. Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis , 2013, Intensive Care Medicine.

[9] A. Greinacher,et al. Thrombocytopenia in the intensive care unit-diagnostic approach and management. , 2013, Seminars in hematology.

[10] E. Wood,et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. , 2013, The New England journal of medicine.

[11] O. Lesur,et al. Thrombocytopenia in the critically ill: prevalence, incidence, risk factors, and clinical outcomes , 2013, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[12] G. Guyatt,et al. Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness. , 2013, Thrombosis research.

[13] A. Ho,et al. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study , 2012, The Lancet.

[14] G. Guyatt,et al. Dalteparin versus unfractionated heparin in critically ill patients. , 2011, The New England journal of medicine.

[15] Wendy Lim,et al. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. , 2011, Chest.

[16] R. Porte,et al. The Impact of Intraoperative Transfusion of Platelets and Red Blood Cells on Survival After Liver Transplantation , 2008, Anesthesia and analgesia.

[17] D. Cook,et al. Bleeding during critical illness: a prospective cohort study using a new measurement tool. , 2007, Clinical and investigative medicine. Medecine clinique et experimentale.

[18] C. Sigouin,et al. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses , 2006, Transfusion.

[19] G. Guyatt,et al. Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors , 2005, Critical care medicine.

[20] Sylvie Chevret,et al. Sample size formula for proportional hazards modelling of competing risks , 2004, Statistics in medicine.

[21] S. Body,et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes , 2004, Transfusion.

[22] D. Schoenfeld,et al. Sample-size formula for the proportional-hazards regression model. , 1983, Biometrics.